Showing results (351-360 of 465) with videos related to

Sort By:
Pageof 47
The Journal of Rheumatology|December 7, 2005
Magnetic resonance imaging in rheumatoid arthritis advances and research prioritiesMikkel Ostergaard, Fiona M McQueen, Paul Bird, et al.
Rheumatology (Oxford, England)|December 19, 2024
Improving the arthritis component of the SLEDAI-2KKhaled Mahmoud, Md Yuzaiful Md Yusof, Lee Suan Teh, et al.
The Journal of Rheumatology|March 4, 2014
How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0Maarten Boers, John R Kirwan, Laure Gossec, et al.
The Journal of Rheumatology|August 3, 2015
Harmonizing Pain Outcome Measures: Results of the Pre-OMERACT Meeting on Partnerships for Consensus on Patient-important Pain Outcome Domains Between the Cochrane Musculoskeletal Group and OMERACTKristine Phillips, Ann Taylor, Philip J Mease, et al.
The Journal of Rheumatology|December 3, 2013
The OMERACT-RAMRIS rheumatoid arthritis magnetic resonance imaging joint space narrowing score: intrareader and interreader reliability and agreement with computed tomography and conventional radiographyUffe Møller Døhn, Philip G Conaghan, Iris Eshed, et al.
RMD Open|September 27, 2017
Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 2: reliability and application to multiple joints of a standardised consensus-based scoring systemLene Terslev, Esperanza Naredo, Philippe Aegerter, et al.
Research Involvement and Engagement|November 12, 2024
Building trust and inclusion with under-served groups: a public involvement project employing a knowledge mobilisation approachAnna M Anderson, Lucy Brading, Laura Swaithes, et al.
Rheumatology and Therapy|March 19, 2026
Achievement and Maintenance of Disease Targets with Upadacitinib in Rheumatoid Arthritis: 2-Year Outcomes from the UPHOLD Real-World StudyAndrew Östör, Eugen Feist, Prodromos Sidiropoulos, et al.
Osteoarthritis and Cartilage|August 31, 2023
Characterization of adverse joint outcomes in patients with osteoarthritis treated with subcutaneous tanezumabJohn A Carrino, Timothy E McAlindon, Tom J Schnitzer, et al.
Arthritis and Rheumatism|September 30, 2008
Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritisVictoria Bejarano, Mark Quinn, Philip G Conaghan, et al.
Pageof 47